Rationale: Loss of fibulin-4 during embryogenesis results in perinatal lethality because of aneurysm rupture, and defective elastic fiber assembly has been proposed as an underlying cause for the aneurysm phenotype. However, aneurysms are never seen in mice deficient for elastin, or for fibulin-5, which absence also leads to compromised elastic fibers. Objective: We sought to determine the mechanism of aneurysm development in the absence of fibulin-4 and establish the role of fibulin-4 in aortic development.
A ortic aneurysms are characterized by abnormal enlargements of the aorta caused by global or localized weakness of the vessel wall. Traditionally, aneurysm formation is believed to involve defects in synthesis or assembly of extracellular matrix (ECM) proteins or accelerated degradation of vascular ECM (reviewed in 1, 2 ) . For example, mutations in the fibrillin-1 (FBN1) or type III ␣ 1 collagen gene (COL3A1) genes are responsible for Marfan syndrome and vascular Ehlers-Danlos syndrome, 3, 4 respectively. Mutations in Fbn1 profoundly affect the formation of microfibrils that surround an elastin core and are required for proper assembly of elastic fibers. 5 Genetically-engineered mice provide further evidence that the vascular ECM is the critical determinant of aneurysm development, including an allelic series of Fbn1 mutant mice, and mice homozygous for null alleles of the genes encoding lysyl oxidase, a crosslinking enzyme for elastin and collagen, and ECM proteins such as fibulin-4 (Fbln4) and biglycan (Bgn). 6 -9 In addition to the disruption of ECM in the vessel wall, alterations of smooth muscle cell (SMC) intracellular contractile proteins have recently been shown to be responsible for subsets of thoracic aneurysms in humans. 10 -12 Two heterozygous mutations in MYH11 (SM myosin heavy chain [MHC]) were identified in kindreds presenting with thoracic aortic aneurysms and/or aortic dissections (TAADs) and patent ductus arteriosus. Heterozygous missense mutations in ACTA2 (SM ␣-actin) were also found in 14% of inherited TAADs. 12 Thus, the pathogenesis of aortic aneurysm formation may involve abnormalities in homeostasis of vascular ECM proteins or abnormal SMC development, or both.
Fibulin-4 belongs to the fibulin family of ECM proteins consisting of seven known members characterized by tandem repeats of calcium-binding epidermal growth factor (cbEGF)like motifs and a C-terminal fibulin module. 13 In the aorta, fibulin-5 is expressed at one magnitude higher than fibulin-4 and its absence leads to compromised elastic fibers with aggregates of elastin, but does not develop aneurysms. 14, 15 Fbln4-null (Fbln4 Ϫ/Ϫ ) mice, in contrast, exhibit a more severe phenotype with perinatal lethality because of rupture of aortic aneurysms and marked disruption of elastic fibers. 8 Genetic mutations in the FBLN4 have also been identified in two human cutis laxa patients, both of which exhibited aortic aneurysms. 16, 17 Defective elastogenesis was proposed to be an underlying cause of aortic aneurysms in Fbln4 Ϫ/Ϫ mice, however, elastin-null mice (Eln Ϫ/Ϫ ) do not develop aortic aneurysms, rather they exhibit stenosis of the aorta because of subendothelial proliferation of SMCs. 18 It is not clear, therefore, whether the phenotypic differences between Fbln4 Ϫ/Ϫ and Fbln5 Ϫ/Ϫ mice are attributable solely to the difference in severity of elastic fiber defects. It is possible that fibulin-4 has additional function(s) that act independent of, or in concert with, elastogenesis in the developing aorta. Recently, hypomorphic Fbln4 R/R mice were shown to contain increased phosphorylated (p)-Smad2, enhanced production of connective tissue growth factor and collagen fibers, and increased proliferation of SMCs in the aortic wall. 19 However, the precise mechanism of upregulation of transforming growth factor (TGF)-␤ in Fbln4 R/R mice or whether it is a primary cause of the vascular phenotype is unclear, especially because SMC-specific ablation of TGF-␤ receptor type 2 causes aortic aneurysms by downregulating elastogenic genes. 20 To determine the role of fibulin-4 in aneurysm formation, we generated mice with a germline deletion or vascular cell-specific deletion of Fbln4. SMC-specific, but not endothelial cell (EC)-specific knockout of Fbln4, resulted in the formation of large aneurysms exclusively in the ascending aorta. We found that SMCs failed to fully differentiate in the absence of fibulin-4 in the aorta as evidenced by downregulation of SMC-specific contractile protein genes and an immature phenotype of Fbln4-null SMCs accompanied by focal hyperproliferation of SMCs and degenerative changes affecting the integrity of the vessel wall. These data highlight a novel role for fibulin-4 in the development of SMCs, and together with its role in the formation of elastic fibers, fibulin-4 functions to protect the aortic wall against aneurysm formation in vivo.
Methods

Mouse
Generation of conditional knockout mice is described in the expanded Methods section, available in the Online Data Supplement at http://circres.ahajournals.org.
Mechanical Stretch
Two or 4ϫ10 5 cells were plated on 6-well silicon elastomerbottomed culture plates covalently coated with type I collagen (Flexcell). After allowing cells to adhere to the plates (6 to 12 hours), the media was changed to serum free and incubated for 24 hours to synchronize the cell cycle before initiation of stretch stimulation. Cells were subjected to unidirectional cyclic strain (0.2 Hz and 20% strain) for 24 hours in a humidified incubator with 5% CO 2 at 37°C using FX-4000T Flexcell Tension Plus system (Flexcell International). Cells incubated in static condition served as controls.
Standard protocol was used for immunostaining, Western blotting, quantitative polymerase chain reaction (qPCR), gelatin zymography, histological, and electron microscopic analysis and is available online.
Results
Germline and SMC-Specific Deletions of Fbln4 In Vivo
To investigate aneurysm development in the absence of fibulin-4, we generated a conditional allele of Fbln4 using Cre-loxP technique in ES cells (Online Figure I, A). Fbln4 neoloxP mice were mated with transgenic mice expressing the heat stable Flp-recombinase to generate mice homozygous for Fbln4 loxP/loxP (Online Figure I , B and C). Fbln4 neoloxP mice were also mated with CAG-Cre transgenic mice to delete Fbln4 in germline, and subsequently homozygous mice for null alleles were generated (termed Fbln4 GKO ). In concordance with the previous reported data, 8 all Fbln4 is ubiquitously expressed during embryogenesis and is detected in both ECs and SMCs in the aorta (Online Figure  II , A and B). To determine the cell type responsible for the aneurysm phenotype, we generated EC-specific and SMCspecific knockout mice for Fbln4 by mating Fbln4 loxP/loxP mice with transgenic mice expressing Cre-recombinase under a control of the Tie2 promoter and SM22␣ promoter, respectively. 21, 22 EC-specific knockout mice (Fbln4 loxP/GKO ;Tie2-Cre, termed Fbln4 ECKO ) were healthy and indistinguishable from control littermates. Histological finding of the aorta was normal (Online Figure III) . In contrast, SMC-specific knockout mice (Fbln4 loxP/GKO ;SM22-Cre, termed Fbln4 SMKO ) be- gan to die spontaneously at approximately 2 months of age despite absence of embryonic or neonatal lethality. Aortae harvested from adult Fbln4 SMKO mice exhibited large aneurysms exclusively in the ascending aorta ( Figure 1A ). Aneurysms were observed in Fbln4 SMKO mice with complete penetrance. The ductus arteriosus was closed and the ligamentous remnant was markedly elongated. qPCR confirmed a significant reduction of Fbln4 transcripts in the ascending aorta where the aneurysms developed, as well as in the descending thoracic aorta where only elongation was evident ( Figure 1B) . These data indicate that loss of SMC-derived fibulin-4 is responsible for the aneurysm formation and that fibulin-4 derived from other cell types compensated for aneurysm formation during embryonic life and perinatal lethality in Fbln4 SMKO mice.
Non-standard Abbreviations and Acronyms
Compromised Elastic Fibers, Increased Wall Thickness, and Disarray of SMCs in the Fbln4 GKO Aorta
To better understand the pathological processes of aneurysm formation in the absence of Fbln4, we performed a developmental analysis of the ascending aorta in Fbln4 GKO embryos. Consistent with a previous observation, 8 elastic fibers were clearly detected in the aortic wall of wild-type embryos at embryonic day (E)14.5, whereas elastic fibers were decreased in the aorta from Fbln4 GKO embryos (Online Figure In advanced lesions with dissection, more infiltrates were observed within the vessel wall (Online Figure V , A ͓b͔). No difference in proMMP-2 or MMP-2 levels was observed between wild-type and Fbln4 GKO descending thoracic aortae (Online Figure V, B ). Interestingly, this focal degeneration of the aortic wall was not detected in embryos younger than E17.5. Because Fbln4 GKO mutants die in or after parturition, we further characterized the aortic wall at E18.5. A significant upregulation of p-ERK in ECs and SMCs was observed in the Fbln4 GKO aorta ( Figure 2f ) and GRP78, a marker of the endoplasmic reticulum stress response, was upregulated in SMCs surrounding the degenerative area (Figure 2h ). Increased apoptotic cells were also observed in both ECs and SMCs in degenerative areas (data not shown) as well as in advanced aneurysmal lesions ( Figure  2j ). These observations suggest that aneurysm development in Fbln4 GKO mice involved not only defective elastic fibers but also abnormal SMCs with degenerative medial wall changes.
Defects in Terminal Differentiation of SMCs in Fbln4 GKO Aorta
Histological abnormalities in SMCs of the Fbln4 GKO aorta led us to further evaluate the SMC phenotype in Fbln4 GKO embryos. Specifically, we examined expression of SMC differentiation markers in wild-type and Fbln4 GKO descending thoracic aortae at E16.5. In the wild-type aorta, SM ␣-actin and SM-MHC, early and late SMC differentiation markers, respectively, were expressed throughout the aortic wall ( Figure 3A , a and c). In the Fbln4 GKO aorta, the intensity of both markers was not homogenous along the longitudinal axis of the aorta, particularly for SM-MHC ( Figure 3A , b and d). At E18.5, SM ␣-actin and SM-MHC levels were increased in both wild-type and mutant aortae. The mutant aorta, however, still exhibited reduced marker expression compared to the wild-type aorta ( Figure 3A , i through l). To confirm these findings, tissue extracts from the descending thoracic aorta devoid of aneurysm lesions from Fbln4 GKO embryos were compared with those of wild-type embryos by Western analysis ( Figure 3B ). Consistent with tissue immunostaining, we observed significant decreases in SM-MHC and ␣-SMactin expression. In addition, a marked increase in MAPK signaling pathways, including p-ERK1/2 and p-MEK1/2, was observed in mutant aortae ( Figure 3B ). Other components of MAPK pathways were only moderately increased in the mutants.
Disrupted Wall Structure and Alterations of SMC Gene Expression in Fbln4 GKO Aorta
It has been shown that the aorta lacking elastin exhibits increased SMC proliferation and changes in SMC organization. 18 We therefore examined aortic ultrastructure at the electron microscopic level in E18.5 embryos. In the wild-type aorta, near continuous elastic laminae were observed throughout the aortic wall, with those closer to the lumen being more completely formed at this time ( Figure 4A , a and c). SMCs maintained close contacts with neighboring cells and developing elastic fibers. In contrast, discontinuous aggregates of elastin were observed in the Fbln4 GKO aorta ( Figure 4A , b, arrow). Higher magnification showed loose cell-cell associations and very few cell-elastin contacts with increased pericellular spaces in the Fbln4 GKO aorta, exhibiting an immature vessel wall ( Figure 4A, d) .
To examine whether the absence of fibulin-4 affected SMC-specific gene expression in the aortic wall, we performed qPCR analysis using E18.5 descending thoracic aorta from wild-type and Fbln4 GKO mice. SMC-specific genes, including Acta2 and Myh11, were downregulated in the mutant aorta ( Figure 4B) , consistent with the data obtained from Western blot and immunostaining analyses ( Figure 3 ). Interestingly, transcription factors involved in SMC differentiation, including Myocd (myocardin), Mkl1 (myocardin-like 1/MAL/MRTF-A), and Mkl2 (myocardin-like 2/MRTF-B) were also downregulated. Because the lack of intact elastic fibers has been shown to affect SMC phenotype in the Eln Ϫ/Ϫ aorta, and recombinant tropoelastin induced actin polymerization without changing actin expression in Eln Ϫ/Ϫ SMCs, 23 the immature phenotypes of Fbln4 GKO SMCs may be secondary to the loss of intact elastic fibers. To examine this possibility, we evaluated the expression profile of SMC marker genes in Eln Ϫ/Ϫ aortae. Transcripts for Myocd, Mkl1, Mkl2, Myh11, or Acta2 were not downregulated in Eln Ϫ/Ϫ aortae (Online Figure VI) . Rather, Myocd, Myh11, and Acta2 were upregulated compared to wild-type aortae. Although we cannot completely distinguish a direct or elastic fibermediated role of fibulin-4 on differentiation of SMCs in the present experimental system, the distinct transcriptional profile of the Fbln4 GKO aorta suggest a unique and/or additional role of fibulin-4 in development of the aortic wall.
Loss of Fibulin-4 Results in an Immature Phenotype in Fbln4 GKO SMCs
To further investigate the effect of loss of fibulin-4 on SMC phenotype, we isolated SMCs from the aorta of wild-type or Fbln4 GKO embryos between E17.5 and E18.5. Morphological analysis with phalloidin staining revealed that stress fibers were decreased and cortical actin staining more prominent in Fbln4 GKO SMCs compared to wild-type SMCs ( Figure 5A ). SM-MHC protein content was markedly reduced in Fbln4 GKO SMCs by Western analysis (Figure 5A, c) . Separation of SM1 (204 kDa) and SM2 (200 kDa) by SDS-PAGE revealed that loss of SM-MHC was predominantly attributable to loss of SM1, the predominant MHC in the developed aorta. SM ␣-actin was highly expressed in SMCs and we did not detect any appreciable difference in SM ␣-actin content between the genotypes by Western blot analysis (data not shown). Next, we examined the capacity of Fbln4 GKO cells to proliferate in the absence of serum, a characteristic feature of embryonictype SMCs. 24 Wild-type and Fbln4 GKO SMCs were allowed to adhere to the culture dish and the medium was changed to a serum-free medium and grown for 24 hour. Immunostaining with anti-p-histone H3, a mitosis marker, showed a significant increase in mitotic cells in Fbln4 GKO SMCs ( Figure 5B , b and d), whereas positive cells were virtually absent in wild-type SMCs (Figure 5B , a and c). Proliferation assays performed following stimulation with 20% FBS also exhibited a marked increase in the proliferation of Fbln4 GKO cells ( Figure 5C ).
Compromised contractile forces resulting from the mutations of genes encoding for SMC-specific contractile proteins or cardiac sarcomeric proteins are proposed to cause familial thoracic aortic aneurysms and familial hypertrophic or dilated cardiomyopathy, respectively. 25, 26 Therefore, it is possible that Fbln4-null SMCs with reduced expression of SMC contractile proteins may exhibit an abnormal response to mechanical strain compared to wild-type SMCs. To examine this possibility, we performed in vitro stretch assays. Wildtype and Fbln4 GKO SMCs were plated on a type I collagen precoated elastomer well and subjected to cyclic stretch (0.2 Hz, 20% strain) for 24 hours without serum. Cells incubated in a static condition served as controls. Changes in SM-MHC and activation of downstream signaling pathways were eval- uated by Western analysis. As Figure 5D (a) shows, wild-type SMCs maintained SM-MHC levels after the stretch stimulation, however, Fbln4 GKO cells showed a marked decrease in SM-MHC levels in both static and stretch conditions compared to wild-type cells (PϽ0.005). Although a trend indicating a decrease in SM-MHC expression was observed after stretch stimulation in mutant cells by densitometric analysis, no statistical significance was obtained (Pϭ0.056). Cyclic stretch showed a moderate increase in p-ERK in Fbln4 GKO SMCs compared to wild-type cells ( Figure 5D, b) ; however, statistical significance was not obtained under the given condition (Pϭ0.088; Figure 5D , c). These data suggest that absence of fibulin-4 results in an immature SMC phenotype with compromised level of SM-MHC and altered proliferative response.
Differentiation Defect of SMCs and Marked Upregulation of p-ERK1/2 in the Fbln4 SMKO Aorta
Finally, we asked if postnatal aneurysms in the Fbln4 SMKO mice share the same underlying pathology as those of Fbln4 GKO mice. Histological analysis of Fbln4 SMKO ascending aorta at postnatal day (P)90 revealed focal lesions with a thickened aortic wall, which was primarily attributable to an increase in medial SMC layers ( Figure 6A, a and d) . Disarray of SMCs was particularly prominent in the outer two-thirds of the aortic wall in which disorganized elastic fibers were also prominent ( Figure 6A, b and e ). Inflammatory infiltrates, including neutrophils and macrophages, were not prominently seen in Fbln4 SMKO aortae. An overall increase of collagen fibers was also detected in the mutant aorta ( Figure  6A, c and f) . Surprisingly, in contrast to the dramatic changes seen in the ascending aorta, the descending thoracic aorta appeared normal without hyperproliferation of SMCs (Online Figure VII, d) . Elastic laminae were more organized compared to those in the ascending aorta, although discontinuities were more frequently observed in mutants compared to the wild-type aorta (Online Figure VII, e ). Masson trichrome staining revealed significant increases in collagen fibers in the mutant descending thoracic aorta (Online Figure VII, f) .
To examine if the differentiation defect of SMCs is also present in the Fbln4 SMKO aorta, qPCR analysis was performed using ascending and descending thoracic aortae from Fbln4 SMKO and control mice at P90. Transcripts for SMC contractile genes were significantly downregulated in the diseased ascending aorta as well as in the descending aorta where no aneurysms were observed ( Figure 6B ). In addition, Myocd was downregulated in both ascending and descending thoracic aortae. Immunostaining of the ascending aorta at P25 with anti-SMemb, a marker of embryonic SMCs, 27 showed faint staining in the wild-type aorta, whereas persistent expression was detected in the mutant aorta ( Figure 6C, a and  c) . In contrast, immunostaining with anti-SM-MHC detected strong expression in P90 wild-type ascending aorta, whereas a marked reduction of SM-MHC was observed in the mutant aorta ( Figure 6C, b and d) . The reduction of SM-MHC levels was further confirmed by Western blot analysis using ascending aortae harvested from P25 and P90 Fbln4 SMKO mice ( Figure 6D ). At both time points, before or after aneurysm Finally, we examined signaling pathways responsible for the proliferative changes of the aneurysmal wall. Upregulation of p-ERK1/2 was observed in the Fbln4 SMKO aorta at P25 and P90 by Western blot analysis ( Figure 7A ). Immunostaining of the P90 ascending aorta revealed strong upregulation of p-ERK1/2 in the mutant SMCs compared to control vessels ( Figure 7B ). Phosphorylated p38 mitogen-activated protein kinase (p-p38) level was moderately increased in the mutant aorta (data not shown). Levels of p-Smad2/3, p-Smad1/5/8, and connective tissue growth factor, a downstream target of TGF-␤, were comparable between control and Fbln4 SMKO aortae examined at P25 and 3-months of age (Online Figure VIII, A͓a͔ and B ). In addition, we did not detect any difference in p-Smad2/3 levels between wild-type and Fbln4 GKO aortae by Western blot or immunostaining (Online Figure VIII, A ͓b͔; data not shown). Taken together, these observations in the Fbln4 GKO and Fbln4 SMKO aortae suggested that (1) alteration of SMC-specific genes was not simply a consequence of aneurysm formation in the mutant aorta and (2) the ERK1/2 pathway played a pivotal role in the focal proliferative response of abnormal SMCs in the aneurysmal wall.
Discussion
Potential Contribution of Abnormal SMCs to Aneurysm Development in Fbln4 Mutant Mice
Deletion of fibulin-4 in a global or SMC-specific manner resulted in a differentiation defect of SMCs with marked downregulation of SMC contractile genes. Contractile forces in SMCs are generated by cyclic interactions of MHC and actin filaments induced by MLCK-mediated phosphorylation of myosin light chains (reviewed elsewhere 28, 29 ). The mutations in components of the contractile apparatus in SMC such as ACTA2 and MYH11 lead to a focal proliferation of SMCs with disarray, disruption of elastic fibers, and eventual loss of SMCs. 10 -12 It is also shown that patients with ACTA2 disease haplotype exhibit reduced aortic compliance and increased pulse velocity, altering aortic stiffness. 10 Although aortic aneurysms were not observed in genetic ablation of the SM2 isoform of SM-MHC in mice, the mutants did develop an enlarged thin bladder and hydronephrosis and died within 4 weeks of age. 30 A concomitant reduction of SM1 was observed in the SM2 Ϫ/Ϫ bladder and an appropriate ratio of SM1 to SM2 was shown to be critical for normal contractility of SMCs. Absence of Acta2 also exhibited a significant decrease in vascular contractility and impaired maintenance of blood pressure and blood flow. 31 Thus, quality and quantity of contractile proteins significantly affect contractile functions of SMCs and eventually affect mechanical properties of the aortic wall. Taken together, we suggest that Fbln4 mutant SMCs with reduced expression of contractile proteins and highly synthetic phenotype, together with the abnormal ECM, alter vessel wall stability and results in maladaptation of the vessel wall, providing a potential link to an aneurysm phenotype ( Figure 7C ). 
Fibulin-4 Provides a Permissive Environment for Differentiation and Maintenance of SMCs
SMC differentiation is largely governed by the myocardin family of transcriptional coactivators (reviewed elsewhere 32 ). Myocardin, Mkl1, and Mkl2 serve as a potent cofactor of SRF and upregulate a variety of SMC contractile genes. [33] [34] [35] [36] The reduced expression of Myocd, Mkl1, and Mkl2 in the Fbln4 GKO mutant aorta indicates a potential mechanism of extracellular regulation of SMC differentiation genes by fibulin-4. Fibulin-4 is located in microfibril bundles which tether elastic fibers to SMCs via integrin-mediated binding at regions of the cell membrane occupied by intracellular membrane-associated dense plaques, anchoring sites for actin filaments. 37, 38 Thus, loss of fibulin-4 may disrupt the interaction between elastic fibers and SMCs, leading to the alterations in actin cytoskeleton organization. The actin dynamics between filamentous (F) and globular (G) actin are known to regulate the activity of Mkl1: G-actin binds to cytoplasmic Mkl1 and inhibits translocation of Mkl1 to the nucleus thereby disrupting the interaction between Mkl1 and SRF and downregulating the transcription of SMC contractile genes. 39 Our observation that actin filaments were less prominent in Fbln4 GKO SMCs compared to wild-type cells is consistent with this hypothesis. A similar disruption of the elastin-SMC connection was reported in a mouse deficient for the polycystic kidney disease 1 (Pkd1) gene, which developed descending aortic aneurysms with hyperproliferative SMCs. 40 Ultrastructural studies of Fbn1 C1039G/ϩ aortae also revealed disruption between SMC and elastic fiber connections, leading to activation of SMCs. 41 Taken together, fibulin-4 is critical for the maintenance of the permissive and stable environment for SMC differentiation.
Elastic Fibers and Protection of Aortic Aneurysms
Our present study, together with other reports, confirmed that a loss of fibulin-4 profoundly affects formation of elastic fibers. 8, 19 Various experimental manipulations that disrupt elastic fibers have successfully recapitulated pathological changes of aortic aneurysms in rodents. 42, 43 Genetic or pharmacological stabilization of elastin or inhibition of its degradation was shown to attenuate development of abdominal aortic aneurysms. 44 -46 Although elastic fibers or insoluble elastin have been shown to suppress proliferation and migration of SMCs, 23 a causal relationship between disrupted elastic fibers and aneurysm formation during development has not been fully established. Interestingly, mice deficient in the fibrillin-1 gene (Fbn1 mgN/mgN ) that die from aneurysm rupture within two weeks of age, exhibit maturation defects of the aortic wall and persistent expression of embryonic SMC markers. 47 Thus, components of elastic fibers affect SMC phenotypes directly or indirectly during development, a time when SMCs have a high degree of plasticity.
Signaling Pathways Involved in Proliferation of SMCs in the Fbln4 Mutant Aorta
Hyperproliferation of SMCs is a critical component involved in the alteration of the Fbln4 mutant aorta and is predominantly mediated by the ERK1/2 signaling. A cue for the activation of ERK1/2 may be provided by mechanical stimuli such as increased hemodynamic force and changes in aortic ECM components, paracrine factors or by undefined mechanisms. Cyclic stretch activates MAPK pathway (both ERK and p38) and increases import of nuclear protein as well as transcription of nuclear pore complex. 48 Although the causal relationship between cyclic strain and ERK1/2 phosphorylation was not established in Fbln4 GKO SMCs using an in vitro system, the observation that aneurysms developed exclusively in the ascending aorta, the region of highest systolic pressure, in Fbln4 SMKO mice suggests that mechanical strain may influence SMC function in vivo. Angiotensin II activates the ERK pathway and is also a known mediator of the stretch response in SMCs through local production of angiotensinogen or local conversion of angiotensin I to angiotensin II. 49 Angiotensin II type 1 receptor blockade inhibits gene transcription and proliferation of SMCs induced by stretch stimulation as well as the hypertrophic response of cardiac myocytes induced by pressure overload. 50 -52 Upregulation of insulin-like growth factor (IGF)-1 and phosphorylation of IGFreceptor is also induced by cyclic stretch and lead to the proliferation of venous SMCs. 53, 54 Interestingly, a high level of angiotensin II and IGF-1 was observed in primary SMC cultures prepared from a patient with a MYH11 mutation, suggesting the possible involvement of these soluble factors in the proliferative response of SMCs. 11 It is also possible that TGF-␤ activates ERK1/2 pathways by a non-Smad-dependent mechanism. 55 Thus, Fbln4 mutant mice give us the opportunity to test pharmacological interventions to block specific signaling pathway and attenuate aneurysm formation in vivo.
Limitation of This Study
Our present study revealed a critical role for fibulin-4 on differentiation of SMCs and protection from aneurysm development. Because fibulin-4 is a secreted protein, our conditional knockout phenotypes may be partially masked by fibulin-4 supplied by adjacent tissues or remaining production of fibulin-4 within the aortic wall. Fibulin-4 plays a critical role in elastic fiber assembly, therefore, the temporal and causal relationship between defective elastic fibers and alteration of SMC phenotype in Fbln4-null aorta remain to be further investigated. In addition, potential cellular functions of fibulin-4 such as the effect on apoptosis or collagen fiber formation, may be explored.
